Koninklijke Philips (PHG) Cash & Current Investments (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Cash & Current Investments of $3.1 billion in Q1 2026, down 6.63% quarter-over-quarter from $3.3 billion in Q4 2025, and up 23.62% on a YoY basis from $2.5 billion in Q1 2025.
Koninklijke Philips (PHG) Cash & Current Investments (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $3.1 billion for Q1 2026.
- In Q1 2026, Cash & Current Investments rose 23.62% year-over-year to $3.1 billion; the TTM figure through Mar 2026 stood at $3.1 billion (up 23.62% YoY), while the FY2025 annual figure was $3.3 billion, up 26.79% from the prior year.
- Cash & Current Investments was $3.1 billion for Q1 2026 at Koninklijke Philips, down from $3.3 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $3.3 billion in Q4 2025 to a low of $1.0 billion in Q3 2023.
- Historically, Cash & Current Investments has averaged $2.1 billion across 5 years, with a median of $2.1 billion in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 54.23% in 2022, then soared 96.41% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $1.2 billion in 2022, then surged by 70.62% to $2.1 billion in 2023, then rose by 28.17% to $2.6 billion in 2024, then grew by 26.79% to $3.3 billion in 2025, then dropped by 6.63% to $3.1 billion in 2026.
- The last three Cash & Current Investments figures came in at $3.1 billion (Q1 2026), $3.3 billion (Q4 2025), and $2.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 3.67 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.29 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 1.12 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn | 424.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.12 Bn |
| Dec 31, 2025 | 3.35 Bn |
| Sep 30, 2025 | 2.33 Bn |
| Jun 30, 2025 | 2.06 Bn |
| Mar 31, 2025 | 2.53 Bn |
| Dec 31, 2024 | 2.64 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 2.02 Bn |
| Mar 31, 2024 | 2.03 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 1.28 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.27 Bn |
| Jun 30, 2022 | 2.47 Bn |
| Mar 31, 2022 | 2.58 Bn |
| Dec 31, 2021 | 2.64 Bn |
| Sep 30, 2021 | 1.20 Bn |
| Jun 30, 2021 | 3.95 Bn |